Skip to content

Laparoscopic Sleeve Gastrectomy With Endoscopic Visualization

Endoscopic Visualization During a Laparoscopic Sleeve Gastrectomy Procedure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00911989
Enrollment
4
Registered
2009-06-03
Start date
2009-07-31
Completion date
2010-12-31
Last updated
2012-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

Obesity, Weight Loss

Brief summary

The main objective of this trial is to evaluate endoscopic visualization during a laparoscopic sleeve gastrectomy (LSG) procedure using an endoscope inserted transvaginally through a new device called a Steerable Flex Trocar (SFT).

Interventions

DEVICENOTES toolbox

Using SFT for endoscope access during Transvaginal Sleeve Gastrectomy procedure. Visualization will occur through endoscope

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Women will be enrolled in this study who: * Are willing to give consent and comply with evaluation and treatment schedule; * Are 21 to 60 years of age (inclusive), post menopausal, or otherwise no longer expect to bear children, e.g., previous tubal ligation; * Are a candidate for surgical weight loss intervention (meets ASMBS and NIH criteria); * Have no significant psychopathology that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behavioral recommendations; * Agree to refrain from any type of elective procedures that would affect body weight such as abdominal lipoplasty or liposuction, mammoplasty, or removal of excess skin for the duration of the trial; * Are American Society of Anesthesiologists (ASA) Class I, II, or III); and * Have a negative pregnancy test (for women of childbearing potential).

Exclusion criteria

Subjects will be excluded from the study for any of the following: * Previous pelvic surgery other than transverse C-sections and/or tubal ligation; * Enlarged uterus; * Evidence of pelvic malignancy on a screening ultrasound; * Documented history of drug and/or alcohol abuse within 2 years of the Screening Visit; * Previous malabsorptive or restrictive procedures performed for the treatment of obesity; * Unable or unwilling to attend follow-up visits and examinations; * Planned or predicted concurrent surgical procedure; * Any medical condition which precludes compliance with the study; * Immunocompromised such as that resulting from chronic oral steroid use, chemotherapeutic agents, or immune deficiency disorders; * Conditions that, in the opinion of the investigator, may jeopardize the subject's well-being and/or the soundness of this clinical study; * History or presence of pre-existing autoimmune connective tissue disease, e.g., systemic lupus erythematosus or scleroderma; * Use of prescription or over the counter weight reduction medications or supplements, participation in weight-loss programs, or change in smoking habits within 8 weeks of the Screening Visit and for the duration of study participation; * Participation in another clinical trial within 8 weeks of the Screening Visit and for the duration of this trial (unless previously approved by the investigator and Sponsor); or * Any condition which precludes compliance with the study (investigator discretion).

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Procedures Completed With Successful Endoscopic Visualization.Assessed intra-operativelyThe goal of the study was to evaluate the feasibility of endoscopic visualization during a laparoscopic sleeve gastrectomy procedure using an endoscope inserted transvaginally through a steerable flex trocar. The number of subjects in whom the procedure was completed with endoscopic visualization was recorded.

Countries

United States

Participant flow

Participants by arm

ArmCount
Transvaginal Sleeve Gastrectomy
Transvaginal Sleeve Gastrectomy using Steerable Flex Trocar (SFT) for transvaginal endoscope placement (endoscopic visualization)
4
Total4

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1

Baseline characteristics

CharacteristicTransvaginal Sleeve Gastrectomy
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Age Continuous48.3 years
STANDARD_DEVIATION 11.64
Region of Enrollment
United States
4 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
4 / 4
serious
Total, serious adverse events
1 / 4

Outcome results

Primary

Proportion of Procedures Completed With Successful Endoscopic Visualization.

The goal of the study was to evaluate the feasibility of endoscopic visualization during a laparoscopic sleeve gastrectomy procedure using an endoscope inserted transvaginally through a steerable flex trocar. The number of subjects in whom the procedure was completed with endoscopic visualization was recorded.

Time frame: Assessed intra-operatively

Population: All subjects on whom the surgery was attempted represent the primary analysis population.

ArmMeasureValue (NUMBER)
Transvaginal Sleeve GastrectomyProportion of Procedures Completed With Successful Endoscopic Visualization.4 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026